Tumor necrosis factor and increase in alveolar capillary barrier in malaria - Reply to Eisenhut

Tumor necrosis factor and increase in alveolar capillary barrier in malaria - Reply to Eisenhut

Detalhes bibliográficos
Main Authors:	Anstey, N, Pain, M, Price, R, Maguire, G
Formato:	Journal article
Publicado em:	2007

Registos relacionados

Reply to Eisenhut [2]
Por: Anstey, N, et al.
Publicado em: (2007)

Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation.
Por: Anstey, N, et al.
Publicado em: (2007)

Author′s reply: Salivary tumor necrosis factor-alpha: The way ahead
Por: Pritma Singh, et al.
Publicado em: (2015-01-01)

The alveolar lining - Reply
Por: Dorrington, K, et al.
Publicado em: (2002)

Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia.
Por: Maguire, G, et al.
Publicado em: (2005)

A miniaturized multicellular platform to mimic the 3D structure of the alveolar-capillary barrier
Por: Michela Licciardello, et al.
Publicado em: (2024-04-01)

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α
Por: Angelo Corti, et al.
Publicado em: (2022-07-01)

Tumor necrosis factor-blocking agents in polymyalgia rheumatica and giant cell arteritis - Reply
Por: Luqmani, R
Publicado em: (2008)

Reply to: Scoring the capillary leak syndrome: towards an individualized gradation of the vascular barrier injury
Por: Jakob Wollborn, et al.
Publicado em: (2022-03-01)

Reconstruction of the alveolar–capillary barrier in vitro based on a photo‐responsive stretchable Janus membrane
Por: Changmin Shao, et al.
Publicado em: (2023-02-01)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
Por: Taylor, P, et al.
Publicado em: (2001)

Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells
Por: W. Cui, et al.
Publicado em: (2010-04-01)

A non-sense mutation and protection from severe malaria - Reply
Por: Pain, A, et al.
Publicado em: (2001)

Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India.
Por: Esther Dalko, et al.
Publicado em: (2016-01-01)

Increased tumor necrosis factor alpha and interleukin-6 serum levels and their correlation with laboratory parameters in patients with imported malaria
Por: Poluga Jasmina, et al.
Publicado em: (2012-01-01)

Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.
Por: Clark, T, et al.
Publicado em: (2009)

Can malaria parasite pathogenesis be prevented by treatment with tumor necrosis factor-alpha?
Por: Avner Friedman, et al.
Publicado em: (2013-03-01)

Reply to “Lobular capillary hemangioma with halo phenomenon”
Por: Mohammed Ibrahim AlJasser, MBBS
Publicado em: (2025-04-01)

Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients
Por: Erik Duijvelaar, et al.
Publicado em: (2024-01-01)

Proteomics of lung tissue reveals differences in inflammation and alveolar-capillary barrier response between atelectasis and aerated regions
Por: Azman Rashid, et al.
Publicado em: (2022-04-01)

Multimodality molecular imaging of the alveolar-capillary barrier in lung disease using albumin based optical and PET tracers
Por: Andrei Molotkov, et al.
Publicado em: (2020-12-01)

A Long-Term Survivor With Alveolar Capillary Dysplasia
Por: Chandler E. Yost, BS, et al.
Publicado em: (2020-08-01)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
Por: Maini, R, et al.
Publicado em: (1998)

Production of tumor necrosis factor-á is increased in urinary tract infections
Por: Neni Susilaningsih, et al.
Publicado em: (2012-12-01)

Serum tumor necrosis factor alpha increased during remission with Etanercept
Por: Miu Nicolae, et al.
Publicado em: (2011-09-01)

Editorial: The Tumor Necrosis Factor Superfamily: An Increasing Role in Breast Cancer
Por: Dirk Geerts, et al.
Publicado em: (2020-12-01)

Production of tumor necrosis factor-a is increased in urinary tract infections
Por: Neni Susilaningsih, et al.
Publicado em: (2015-12-01)

Yu-Ping-Feng Formula Ameliorates Alveolar-Capillary Barrier Injury Induced by Exhausted-Exercise via Regulation of Cytoskeleton
Por: Di Wang, et al.
Publicado em: (2022-06-01)

Gene transfer of MRCKα rescues lipopolysaccharide-induced acute lung injury by restoring alveolar capillary barrier function
Por: Jing Liu, et al.
Publicado em: (2021-10-01)

Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential
Por: Sergio Esquivel-Ruiz, et al.
Publicado em: (2021-11-01)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
Por: Leonardo, L, et al.
Publicado em: (2022)

CEREBRAL MALARIA - REPLY
Por: Kirkham, F, et al.
Publicado em: (1991)

Malaria risk - Reply
Por: Snow, R, et al.
Publicado em: (2005)

Albuterol Improves Alveolar-Capillary Membrane Conductance in Healthy Humans
Por: Natalie E. Taylor, et al.
Publicado em: (2016-10-01)

Albuterol Improves Alveolar-Capillary Membrane Conductance in Healthy Humans
Por: Natalie E. Taylor, et al.
Publicado em: (2016-01-01)

Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria.
Por: Looareesuwan, S, et al.
Publicado em: (1999)

Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles.
Por: McGuire, W, et al.
Publicado em: (1999)

Primaquine for plasmodium vivax malaria treatment – authors' reply
Por: Price, RN, et al.
Publicado em: (2020)

Non-infectious immune complexes downregulate the production of interferons and tumor necrosis factor-α in primary porcine alveolar macrophages in vitro
Por: Liujun Zhang, et al.
Publicado em: (2024-06-01)

Tumor Necrosis Factor and Splenectomy
Por: İrfan Yavaşoğlu
Publicado em: (2016-05-01)